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Burkholderia is a diverse genus of gram-negative bacteria that causes high mortality
rate in humans, equines and cattle. The lack of effective therapeutic treatments
poses serious public health threats. Developing insights toward host-Burkholderia
spp. interaction is critical for understanding the pathogenesis of infection as well as
identifying therapeutic targets for drug development. Reverse-phase protein microarray
technology was previously proven to identify and characterize novel biomarkers and
molecular signatures associated with infectious disease and cancer. In the present
study, this technology was utilized to interrogate changes in host protein expression
and phosphorylation events in macrophages infected with a collection of geographically
diverse strains of Burkholderia spp. The expression or phosphorylation state of 25
proteins was altered during Burkholderia spp. infections of which eight proteins were
selected for further characterization by immunoblotting. Increased phosphorylation of
AMPK-α1, Src, and GSK3β suggested the importance of their roles in regulating
Burkholderia spp. mediated innate immune response. Modulating the inflammatory
response by perturbing their activities may provide therapeutic routes for future
treatments.
Keywords: Burkholderia mallei, Burkholderia pseudomallei, lipopolysaccharide, reverse-phase protein
microarrays
Introduction
Burkholderia pseudomallei (Bp) and Burkholderia mallei (Bm) are facultative intracellular gram-
negative bacterial pathogens that cause melioidosis and glanders, respectively. While genetically
similar, Bp and Bm are associated with their own hallmarks. Bp is endemic to tropical regions
of Southeast Asia, Northern Australia, and China, where it inhabits the soil and stagnant water.
Routes of human infection include inhalation, ingestion, and contact with open wounds; however,
human-to-human transmission is extremely rare (White, 2003; Gilad, 2007; Galyov et al., 2010).
Symptomatic infection may present with ﬂu-like symptoms such as fever and pulmonary distress,
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making accurate diagnosis of melioidosis diﬃcult in the early
stages (Dance, 1991; Leelarasamee, 2004; De Keulenaer and
Cheng, 2006). Fatal infection is often due to progression to
septicemia and acute pneumonia (Dance, 1991, 2000; Dharakul
and Songsivilai, 1999; Galyov et al., 2010). By contrast, Bm is
a non-motile obligate mammalian pathogen endemic among
domestic animals in Africa, Asia, the Middle East, and Central
and South America (Whitlock et al., 2007). Equine species are the
natural reservoir for Bm and are responsible for transmission of
glanders to humans through contact, leading to development of
pneumonia and septicemia, often resulting in fatality (Whitlock
et al., 2007; Galyov et al., 2010; Van Zandt et al., 2013). Given
that both species are highly infectious via aerosolization, coupled
with the lack of vaccines, Bp and Bm are considered category
B bioterrorism agents by the U. S. Centers for Disease Control
(Holden et al., 2004; Whitlock et al., 2007; Galyov et al., 2010).
Bp and Bm are resistant to many traditional antibiotics
(Whitlock et al., 2007; Estes et al., 2010; Galyov et al., 2010).
Although successful treatment is possible with several months
of a combination antimicrobial regimen, relapse is common
(Holden et al., 2004; Estes et al., 2010). Eﬀort has been placed
on evaluating the therapeutic potential of bacterial secretion
systems and eﬀectors as components of candidate vaccines
(Whitlock et al., 2007); however, none are available at this time.
Additional therapeutic strategies are required for controlling
disease in endemic regions as well as for protection against
potential bioterrorism threats. Immunotherapy in conjunction
with antimicrobials is a new theme in the Burkholderia
treatment paradigm. A promising study found that combining
interferon (IFN)-γ with an antimicrobial showed synergistic
inhibition of growth in Bp infected macrophages (Propst et al.,
2010). Identiﬁcation of additional host targets that function in
resolving the overactive immune and inﬂammatory responses
elicited by infection is an active area of research (Ulett et al.,
2000).
Pattern recognition receptors (PRRs) are innate immune
sensors that serve as the ﬁrst line of defense against
pathogen infections. Toll like receptor 4 (TLR4) is a PRR
that detects lipopolysaccharide (LPS) expressed on the surface of
Burkholderia spp. TLR4 activation recruits two adaptor proteins,
myeloid diﬀerentiation primary response gene 88 (MyD88) and
TIR-domain-containing adapter-inducing interferon-β (TRIF).
The TRIF-dependent pathway mediates the upregulation of type
I IFN and subsequent phosphorylation of Signal Transducers and
Activators of Transcriptions (STATs). The MyD88-dependent
pathway leads to the activation of IKKα and IKKβ, which
speciﬁcally phosphorylate two serines on the cytoplasmic NF-κB
inhibitor, IκB. Phosphorylation of IκB causes its ubiquitin-
dependent degradation, leading to the activation and nuclear
translocation of NF-κB (Akira et al., 2006). In addition to the NF-
κB pathway, TLR4 also activates Stress Activated Protein Kinases
(SAPK) such as p38 via apoptosis signal-regulating kinase 1
(ASK1), a MAP kinase kinase kinase (MEKK; Matsuzawa et al.,
2005). Although surrogate ligand-mediated (e.g., LPS) pro-
inﬂammatory pathway is extensively studied, the role of Bp and
Bm LPS in human melioidosis or glanders is just beginning to
unravel (Chantratita et al., 2013; Alam et al., 2014). Furthermore,
larger molecular signaling networks that are critical for invasion,
survival and replication of Burkholderia spp. in the host require
characterization.
Reverse-phase protein microarray (RPMA) is a quantitative,
high throughput tool that enables interrogation of changes
in protein expression and post-translational modiﬁcation in
complex cellular signaling networks upon perturbation. This
technology has been successfully utilized to proﬁle molecular
signatures and functional pathway activation associated with
ovarian and breast cancer, respectively, (Sheehan et al., 2005;
Wulfkuhle et al., 2012). Furthermore, phosphorylation states
of key host signaling proteins were characterized in human
samples infected with highly pathogenic agents such as Rift
valley fever virus and Yersinia pestis (Popova et al., 2010; Alem
et al., 2015). The goal of this study was to comprehensively
examine whether diverse strains of Bp, Bm, and Burkholderia
thailandensis (Bt) trigger signaling through common or distinct
host pathways. To this end, we utilized a RPMA platform to
simultaneously detect changes in the expression of host signaling
proteins as well as alterations in phosphorylation-mediated host
signaling caused by infection with Burkholderia spp. To generate
host protein expression and phosphorylation proﬁles, RAW264.7
murine macrophages were infected with geographically diverse
isolates of Bp and Bm, and at various time points protein
lysates were examined using RPMA. This approach identiﬁed 25
candidates whose expression levels and/or phosphorylation states
were altered, of which eight proteins were selected for further
characterization through immunoblot analysis. Consistent with
published studies, we identiﬁed phosphorylation of glycogen
synthase kinase 3 beta (GSK3β) and components of the NF-
κB and MAPK pathways, validating the RPMA approach.
Moreover, we report phosphorylation of additional host proteins
that were not previously linked to Burkholderia spp. infection,
including AMP activated protein kinase (AMPK-α1) and Src.
The signaling architecture is similar between Burkholderia
spp. with minor distinctions in the magnitude of activation
or induction for iNOS, phosphorylated GSK3β and STAT1
and c-Myc. Pharmacological perturbation of these critical
cascades may serve as therapeutic routes for Burkholderia spp.
infections.
Materials and Methods
Bacterial Strains
Bm ATCC 23344, NCTC 10247, NCTC 10229, NCTC 3708,
NCTC 3709, 2002721278 (Burtnick et al., 2002); Bp E8, 576,
MSHR305 (Bast et al., 2011; Van Zandt et al., 2012) and
Bt DW503 were used in this study. Burkholderia spp. were
maintained on Luria Broth (LB) plates with 1.5% agar or on 5%
sheep blood agar (SBA) plates. Bp and Bt strains were cultured in
LB whereas Bm strains were propagated in LB with 4% glycerol.
Bacterial concentrations were quantiﬁed using optical density
(OD) at 600 nm readings and diluted using a conversion factor
of 5 × 108 CFU/ml per unit of OD. All studies using viable
Bp and Bm isolates were performed using biosafety level three
conditions.
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Cell Lines
Mouse macrophage cell line RAW264.7 was obtained from
ATCC (Manassas, VA). Cells were cultured in DMEM (Life
Technologies) supplemented with 10% fetal bovine serum
(Hyclone), 1% nonessential amino acids (Sigma-Aldrich), and 1%
glutamax (Life Technologies), grown at 37◦C in 5% CO2.
Antibodies
For the RPMA studies, only validated antibodies known to cross
react with murine target proteins were selected (Supplementary
Table S1). For immunoblotting, the following antibodies were
purchased from Cell Signaling Technology: iNOS (#2977),
IκBα (#9242), phospho STAT1 (#9171), phospho p38 (#9211),
phospho ERK1/2 (#9101), phospho AMPK-α1 (#4184), total p38
(#2387), phospho Src (#6943), c-Myc (#9402), phospho GSK3β
(#9331). GAPDH was purchased from Sigma-Alrich (G9545).
Total GSK3α/β was purchased from Santa Cruz biotechnology
(SC-56913). Total ERK1 was purchased from BD Transduction
laboratories (M12320).
Infection of RAW264.7 Macrophages
RAW264.7 macrophages (1 × 106 cells/well) were seeded
overnight in six well plates. The next day, cells were infected
with one Bt, ﬁve Bm, and three Bp strains at multiplicity of
infection (MOI) of 1 and 10. In parallel, cells were stimulated with
Escherichia coli LPS at 100 ng/ml. Uninfected and unstimulated
cells were used as negative controls. RAW264.7 cell samples
were collected at 30 min, 1, 4, and 8 h post Burkholderia spp.
infection, washed with phosphate buﬀered saline (PBS) and
lysed. For the longer incubation time points of 4 and 8 h,
extracellular bacteria were removed 2 h post infection by washing
the cells three times with PBS and then further incubated with
pre-warmed DMEM containing 10% fetal bovine serum and
250 μg/ml of kanamycin (Km) (Brett et al., 2008) to reduce
extracellular bacterial growth. All experiments were performed
on two independent days and each biological sample lysate was
printed in triplicate on nitrocellulose coated glass slides.
Reverse Phase Antibody Array
For RPMA assays, cells were harvested, washed with PBS, and
then lysed in a mixture of T-PER Reagent (Thermo Scientiﬁc)
and 2X Tris-Glycine SDS sample buﬀer (Life Technologies),
complete protease inhibitor cocktail (Roche), Na3VO4, NaF,
EDTA, and DTT. RPMAs were constructed and analyzed as
previously described (Improta et al., 2011; Federici et al., 2013).
Samples from duplicate sets of Burkholderia spp. infections were
printed in triplicate spots on nitrocellulose coated glass slides
(GRACE Bio-Labs, Inc.) using an Aushon 2470 microarrayer
equipped with 185 μm pins (Aushon Biosystems), according
to manufacturer’s instructions. A subset of the printed array
slides was stained with Spyro Ruby Protein Blot Stain (Life
Technologies) to estimate sample total protein concentration.
Before staining, proteins array slides were treated with 1X ReBlot
Mild Solution (Chemicon) for 15 min, washed two times for
5 min in PBS (Life Technologies), and incubated for 1 h in
blocking solution (2% I-Block, 0.1% Tween-20 in PBS; Life
Technologies). Immunostaining was performed on an automated
slide stainer using a signal ampliﬁcation kit (DAKO). The
arrays were probed with a collection of 114 antibodies. Primary
antibody binding was detected using a biotinylated goat-anti
rabbit immunoglobulin G (IgG) H+ L at 1:7,500 dilution (Vector
Laboratories) or rabbit anti-mouse IgG at 1:10 dilution (DAKO)
followed by streptavidin-conjugated IRDye680 ﬂuorophore (LI-
COR Biosciences). All slides were scanned using a Revolution
4550 scanner (Vidar Systems Corporation), and acquired images
were analyzed with MicroVigene v.4.0.0.0 (VigeneTech Inc.),
which conducted spot detection, local background subtraction,
negative control subtraction, replicate averaging, and total
protein normalization, producing a single value for each sample.
RPMA Data Analysis
Reverse-phase protein microarray data for 15 out of the 114
antibodies used in the study had expression values around
zero. As we could not assess whether these values represent
true biological values or are a consequence of experimental
and array processing procedures, data from these 15 antibodies
was not included in further analyses. Technical replicates were
independently averaged to generate a value for each biological
sample. Expression values for individual biological replicates
were corrected by normalizing to the value of the uninfected
control condition. Fold-change values were generated for each
time point. Biological replicates were averaged and those for
which the average fold change remained twofold or larger
(i.e., fold-change ≤ 0.5 for under-expressed proteins or fold
change ≥2 for over-expressed proteins) were included in further
analysis.
Immunoblotting
For immunoblot analysis, RAW264.7 macrophages infected at
MOI 10 were pelleted and lysed in radioimmunoprecipitation
assay (RIPA) buﬀer (Thermo Scientiﬁc) containing complete
protease inhibitor cocktail (Roche), and phosphatase inhibitors
(Roche). The amount of total protein in each sample was
quantiﬁed by Bradford assay (Bio-Rad). RAW264.7 cell lysate
preparations were boiled for 10 min with NuPAGE LDS Sample
Buﬀer (Life Technologies) containing 10% 2-Mercaptoethanol.
Equivalent amounts of total protein were loaded onto 4–12%
Bis-Tris gradient gels (Life Technologies) and electrophoresed.
Following electrophoresis, proteins were transferred to a
nitrocellulose membrane (Life Technologies) and then blocked
in 5% bovine serum albumin for 1 h prior to incubation with
primary antibodies overnight. Blots were washed, then incubated
with appropriate HRP-conjugated secondary antibodies (Jackson
ImmunoResearch). Signal was detected by ECL Prime (GE
Healthcare Life Sciences). Image acquisition was performed with
ChemiDocTM XRS+ system (Bio-Rad). Relative protein levels
were normalized with endogenous GAPDH as a loading control.
Immuno-Fluorescence Staining
RAW264.7 macrophages (4 × 104 cells/well) were seeded in
a Falcon 96 well ﬂat bottom plate (REF353219). Cells were
stimulated with 1μg/ml of LPS or infected with Bm ATCC23344,
Bm 2002721278, and Bp E8 at MOI of 10. At 30 min, 1,
4 and 8 h post infection, cells were washed and ﬁxed with
Frontiers in Microbiology | www.frontiersin.org 3 July 2015 | Volume 6 | Article 683
Chiang et al. Burkholderia spp. mediated signal transduction
formaldehyde. Immuno-ﬂuorescent staining of phospho ERK1/2
(Cell Signaling Technology #9101) was performed according to
the manufacturer’s protocol. Images were acquired by Opera
confocal reader (model 3842) using a 20X water objective.
Analysis of the imageswas accomplished within the Opera system
using standard Acapella scripts.
Colony Forming Unit (CFU) Assay to Quantify
Bacterial Uptake and Intracellular Replication
RAW264.7 macrophages (2 × 105 cells/well) were seeded in 24
well tissue culture plates and incubated overnight at 37◦C with
5% CO2. Cells were infected with Burkholderia spp. at an MOI
of 10, and after 1 h infected cells were treated with or without
aminoguandine (200 μg/ml, Sigma-Aldrich; Brett et al., 2008).
Two hours post-infection, cells were washed three times with
PBS to remove extracellular bacteria and then further incubated
with pre-warmed DMEM containing 10% fetal bovine serum and
250 μg/ml of Km. At 3 and 24 h post-infection, supernatants
were harvested and macrophage monolayers were washed two
times with PBS and lysed with 0.1% (vol/vol) Triton X-100.
Serial dilutions of the lysates were plated onto SBA plates. After
incubation for 48 h at 37◦C, colonies were counted and CFU/ml
was computed.
Quantification of Nitrite and Murine IFN-β
Supernatants harvested from the above assay were evaluated
for nitrite and IFN-β production using a Nitric Oxide Assay
Kit (Thermo Scientiﬁc) and mouse IFN-β ELISA kit (Thermo
Scientiﬁc), respectively.
Results
Identification of Host Factors that were
Differentially Expressed upon Burkholderia
spp. Infection
To gain insight into host proteins that are diﬀerentially expressed
or post-translationally modiﬁed following Burkholderia spp.
infection, a high throughput RPMA-based screening platform
was utilized. RAW264.7 macrophage were adopted due
to its ability to phagocytose Burkholderia spp., which in
turn exploits the host’s cellular systems by promoting host
actin polymerization on the bacterial surface and inducing
multinucleated giant cells (MNGCs) formation (Galyov et al.,
2010; Pegoraro et al., 2014). Host responses to a collection of
nine Burkholderia spp. originating from various geographical
locations isolated from human, animals, or environmental
sources were investigated. The ancestry for the majority of the
strains is known along with their virulence proﬁles and genome
sequences. RAW264.7 macrophage lysates harvested at various
time points post Burkholderia spp. infection were individually
arrayed onto nitrocellulose coated slides and probed with a
total of 114 well characterized antibodies (Figure 1A). Statistical
analysis revealed 25 candidates whose change in expression
was twofold or higher in both replicates in any strain, at any
time point and at MOI of 10 (Figure 1B; Supplementary
Figure S1). At MOI of 1, very few robust changes were observed
in host signaling molecules. Hence, subsequent studies were
performed using MOI of 10. RPMA data analysis did not
identify any proteins whose expression was considerably down
regulated compared to uninfected and untreated control. The
selected candidates were further characterized by performing
traditional immunoblots using cell lysates collected from
RAW264.7 macrophage treated with LPS, or infected with
Bm ATCC23344, and Bp E8. Although not included in the
initial RPMA, Bm 2002721278, an avirulent strain (personal
communication), was included for purposes of comparative
analyses of host signaling dynamics between virulent and
avirulent Bm.
Burkholderia spp. Infection Induces iNOS
Expression and Activation of STAT1
RPMA revealed iNOS expression was elevated 1 h post
Burkholderia spp. infection, then reduced at 4 h and restored
by 8 h (Figure 2A). Immunoblotting of independently prepared
lysates samples revealed robust up-regulation of iNOS 8 h post
Bm ATCC2334 and Bm 2002721278 infection. Furthermore, Bp
E8 was a weaker inducer of iNOS expression when compared
to both Bm strains (Figures 2B,C). Aminoguanidine (AG), an
iNOS inhibitor, was utilized to correlate the importance of
iNOS activity with clearance of intracellular Burkholderia spp. in
RAW264.7 macrophages. The colony formation assay conducted
3 h post Burkholderia spp. infection suggested AG did not aﬀect
the uptake of bacteria. Treatment with AG augmented or restored
replication of Bm strains in RAW264.7 macrophages 24 h post
infection. Conversely, AG did not impact bacterial replication in
Bp strains (Figure 2D). The eﬃcacy of AG mediated inhibition
of iNOS was further conﬁrmed by quantifying nitrite production.
AG inhibited Bm mediated nitrite production by approximately
80% whereas only basal levels of nitrite production was observed
in Bp (Figure 2E). This is consistent with reported observations
that iNOS expression was strongly induced when infected
by Bm but not Bp (Utaisincharoen et al., 2001; Brett et al.,
2008).
Infection of macrophages by Gram-negative bacteria induces
the production of IFN-β (Utaisincharoen et al., 2003), which
acts in autocrine or paracrine fashion and triggers subsequent
STAT1 phosphorylation (Gao et al., 1998). Attenuation of iNOS
gene expression in LPS stimulated, IFN-β deﬁcient macrophages
underscores the importance of IFN-β in modulating host innate
immune responses (Thomas et al., 2006). To examine whether a
relationship exists between IFN-β production and the induction
of iNOS in the strains included in our study, culture supernatants
were assayed for IFN-β by ELISA. When grouped, Bm infected
RAW264.7 macrophages showed signiﬁcant elevation of IFN-
β production when compared to the Bp group (Bp E8 and
Bp 576; p-value < 0.001) and Bp and Bt (Bp E8, Bp 576,
Bt DW503) as a group (p-value < 0.00013). Furthermore,
Bt was the least potent inducer among all the strains
inspected in this study (Figure 2F). IFN-β mediated signal
activation was further conﬁrmed by immunoblotting for levels of
STAT1 phosphorylation. Quantiﬁcation of the phospho-STAT1
immunoblot shows increased activation of STAT1 in Bm strains
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FIGURE 1 | A schematic diagram of the experimental design and
overview of the results. (A) Lysates harvested from Burkholderia spp.
infected RAW264.7 macrophages were arrayed on nitrocellulose coated
slides. Each slide was incubated with one primary antibody with a total
of 114 antibodies in the library. The primary antibody was detected by
biotin-labeled secondary antibody, which, in turn, was recognized by
IRDye680 fluorophore conjugated streptavidin. Signals were acquired,
quantified, and analyzed according to materials and methods section.
(B) RAW264.7 macrophages were infected at multiplicity of infection
(MOI) of 10 with indicated Burkholderia spp. for 0.5, 1, 4, and 8 h.
Lysates were harvested and subjected to reverse-phase protein
microarray (RPMA) studies. A heat map of fold changes over untreated
samples is depicted. Experiments were performed on two independent
days and data from these repeat studies are shown.
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FIGURE 2 | Induction of iNOS and activation of STAT1 in response to
Burkholderia spp. infection. (A) The expression pattern of iNOS obtained
from RPMA study. (B) RAW264.7 macrophages were infected with
Burkholderia pseudomallei (Bp) E8, Burkholderia mallei (Bm) 23344, and Bm
2002721278 at MOI of 10, or treated with LPS at 100 ng/ml. Samples were
collected at 0.5, 1, 4, and 8 h post treatments. The amount of iNOS and
phosphorylated STAT1 was evaluated by immunoblotting, followed by (C)
densitometric quantification of iNOS. N.D. indicates signal was not
detectable. (D) Colony forming unit (CFU) was determined 3 and 24 h post
Burkholderia spp. infection of RAW264.7 cells, with and without
aminoguanidine (AG) treatment. Culture supernatants harvested at 24 h post
infection from mock-infected and Burkholderia spp. infected RAW264.7
macrophages were assayed for the production of (E) nitrite and (F) IFN-β.
P-values between species were calculated by Mann–Whitney U test.
∗∗∗p-value < 0.001. (G) densitometric quantification of phosphorylated
STAT1. Immunoblots in Figures 2–4 were performed concurrently from the
same samples and loading control, GAPDH. The immunoblot data is
representative of three independent trials. Bacterial CFUs represent the
average of two biological replicates. Nitrite and IFN-β levels were computed
by averaging three biological replicates.
versus Bp, which demonstrates distinct signaling dynamics
between species (Figures 2B,G).
Burkholderia spp. Induced NF-κB Mediated
Responses
NF-κB pathway constitutes an important part of the host defense
against pathogens (Akira et al., 2006). Several key regulators of
NF-κB signaling pathway were also identiﬁed by RPMA. These
include the phosphorylated forms of Src and GSK3β (Sasaki
et al., 2005; Steinbrecher et al., 2005; Han et al., 2010). RPMA
detected changes in Src andGSK3β phosphorylation (Figure 3A).
The activities of these proteins were later characterized by
immunoblotting. Phosphorylated Src, an integrin associated non-
receptor tyrosine kinase, accumulated over time throughout the
course of the study (Figures 3B,C). Furthermore, the level of
phosphorylated GSK3β at serine 9 and 21, conferring the inactive
form, increased over time in RAW264.7 macrophages treated
with LPS, infected by Bm ATCC23344 and Bp E8. No apparent
accumulation of phosphorylated GSK3β was observed in Bm
2002721278 infected RAW264.7 macrophages (Figures 3B,C).
Activation of NF-κB ﬁrst requires phosphorylation of IκBα,
which primes IκBα for ubiquitination and proteasome-mediated
degradation. NF-κB subsequently translocates to the nucleus and
activates a series of genes involved in the inﬂammatory response
(Thanos and Maniatis, 1995). Although no dramatic changes in
the expression level of total IκBα or phosphorylated IκBα were
observed in the RPMA dataset, immunoblot analysis showed
that cell lysates from LPS treated RAW264.7 macrophages were
void of IκBα at 30 min post stimulation; however, it was quickly
resynthesized by the 1 h time point. The expression level of IκBα
remained intact at 4 and 8 h under LPS stimulation. After Bp and
Bm infections, IκBα expression was absent at 30 and 60 min but
was detected by 4 h, and maintained at 8 h. The avirulent Bm
2002721278 strain showed reduced expression of IκBα compared
to the virulent strains (Figure 3B).
Alternation of Intracellular Energy Level upon
Burkholderia spp. Infection
AMPK-α1 is a serine/threonine protein kinase that has emerged
as a master sensor of cellular energy balance in mammalian
cells (Carling et al., 2011). However, post-translational
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FIGURE 3 | Burkholderia spp. induces NF-κB mediated responses.
(A) The phosphorylation state of indicated proteins acquired by RPMA.
(B) Samples were prepared as described in Figure 2B. The
expression or phosphorylation state of indicated proteins was evaluated
by immunoblotting, followed by (C) densitometry quantification.
Immunoblots in Figures 2–4 were performed concurrently with the
same sample and loading control, GAPDH. The immunoblot data is
representative of three independent trials.
modiﬁcation of AMPK-α1 has not been implicated in the
pathogenesis of Burkholderia spp. infections. The abundance
of AMPK-α1 phosphorylation at an inhibitory site was
altered in RPMA (Figure 4A). Immunoblot analyses
conﬁrmed increased expression of this phosphorylated
form of AMPK-α1 after 1 h, which remained elevated
throughout LPS stimulation or Burkholderia spp. infections
(Figures 4B,C).
Activation of MAPK Pathway in Response to
Burkholderia spp. Infections
Reverse-phase protein microarray identiﬁed multiple
components of MAPK pathway. These included c-Myc and
phosphorylated forms of ASK1, p38, and ERK (Figures 1
and 5A). Immunoblot analyses revealed elevated expression
of phosphorylated p38 over the time course of treatments
(Figures 5B,C). Both immunoblotting and immuno-ﬂuorescent
assay showed an increase in phosphorylated ERK at 30 min
and 1 h post treatment (Figure 5D). This expression pattern
matched the RPMA result where the phosho-ERK1/2 signal
peaked at 1 h. c-Myc, a downstream transcription factor of
p38, was robustly up-regulated 4 h post LPS stimulation and
Burkholderia spp. infection. c-Myc expression was sustained 8 h
post Bm ATCC23344 and Bp E8 infection but was attenuated in
macrophages infected with Bm 2002721278 or treated with LPS
(Figures 5B,C).
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FIGURE 4 | AMPK-α1 is phosphorylated upon Burkholderia spp.
infection. (A) The phosphorylation state of AMPK-α1 acquired by
RPMA. (B) Samples were prepared as described in Figure 2B. The
phosphorylation state of AMPK-α1 was evaluated by immunoblotting,
followed by (C) densitometry quantification. Immunoblots in Figures 2–4
were performed concurrently with the same sample and loading control,
GAPDH. The immunoblot data is representative of three independent
trials.
Discussion
Identification of Gross Changes in Host Protein
Expression and Phosphorylation During
Burkholderia spp. Infection
In this study, we undertook quantitative analysis of
phosphoprotein signaling induced by Burkholderia spp. in
RAW264.7 macrophages using an RPMA platform. This
approach allowed us to simultaneously analyze changes in
phosphorylation states or total protein levels for 114 protein
species, across nine Burkholderia isolates, at two MOI and four
diﬀerent time points. We did not observe any strain speciﬁc
up/down regulation or activation of proteins queried at either
MOI (Supplementary Figure S1). RPMA screening identiﬁed 25
candidate proteins whose expression or phosphorylation states
were altered during Burkholderia spp. infections. The observed
diﬀerences in the host signaling are not a result of defects in
bacterial entry or replication within macrophages, as all the
Bp, Bm, and Bt strains were able to eﬃciently replicate within
macrophages (data not shown; Pilatz et al., 2006; Brett et al.,
2008; Wand et al., 2011). Eight proteins were selected for further
characterization by immunoblotting. Although both RPMA
and immunoblotting approaches revealed changes in protein
expression levels after Burkholderia spp. infection, the kinetic
expression proﬁles of these proteins were slightly diﬀerent.
For example, phosphorylated AMPK-α1 signal obtained from
RPMA peaked at 1 h post infection, attenuated by 4 h and
restored by 8 h. On the contrary, immunoblot analyses showed
a time dependent increase of phosphorylated AMPK-α1 with
a peak at 4 h. The observed diﬀerence may be attributed to
the existence of variations in the microenvironment of the
immobilized cell extracts within and across arrays, such as
possible spatial inconsistencies on the nitrocellulose surface,
non-uniform reagent treatment, or printing inconsistencies
(Anderson et al., 2009). Furthermore, fundamental diﬀerences
exist between the RPMA and immunoblot sample preparation
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FIGURE 5 | Activation of MAPK pathway components upon
Burkholderia spp. infection. (A) The expression and phosphorylation
states of indicated proteins acquired by RPMA. (B) Samples were prepared
as described in Figure 2B. The expression and phosphorylation states of
indicated proteins were evaluated by immunoblotting, followed by (C)
densitometry quantification. (D) RAW264.7 macrophages were stimulated
with lipopolysaccharide (LPS) or infected with Burkholderia spp. at indicated
time points. Phosphorylation of ERK1/2 was visualized by indirect
immuno-fluorescent staining. Expression of phosphorylated ERK1/2 was
subsequently quantified using the Opera confocal system. Phosphorylated
ERK1/2 is pseudocolored green and nuclear stain is colored blue. The
immunoblot data is representative of three independent trials.
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and experimental methods. For example, the ﬂuorophore used
in the RPMA platform is highly sensitive with a broad dynamic
range compared to the chemiluminescence detection system,
resulting in diﬀerent relative signal outputs. These variations
may contribute to the disparity we observe in peaks of expression
between the two assays. Despite the variation between the
observed protein expression kinetics, our goal to identify critical
host factors is not undermined.
The signaling pathways altered in Burkholderia spp. infected
RAW264.7 macrophages include AMPK-α1, regulators of NF-
κB signaling pathway (IκBα, GSK3β, Src, STAT1) and MAPK
(p38, ERK1/2, c-Myc). Notably, RPMA platform study by
Molero et al. (2009) revealed both MAPK and GSK-3β activities
are exploited by Salmonella enterica Serovar Typhimurium (S.
Typhimurium) encoded type III secretion systems (T3SS) during
the internalization process. Internalization of S. Typhimurium is
dependent on the function of Cdc42- and Rac1-activating factors
SopE/E2, which promotes actin rearrangement. A third eﬀector
protein, SigD, which also contributes to bacterial internalization,
triggered Akt activation which subsequently led to GSK-3β
inhibition by phosphorylation on serine 9. Cells pretreated with
a p38 inhibitor showed signiﬁcantly reduced Bp entry; however,
the exact component of the T3SS that mediates this process has
yet to be identiﬁed (Hii et al., 2008). The ability of Burkholderia
spp. to alter phosphorylation states of several MAPK family
members and GSK-3β (Serine 9) suggests both MAPK and GSK-
3β are within a conserved axis exploited during the Burkholderia
pathogenesis.
Manipulation of host kinase signaling by bacterial eﬀectors is
a major mechanism in the pathogenesis of infection (Krachler
et al., 2011). It was reported that Bp T3SS contribute to
activation of host proteins such as NF-κB and JNK in a TLR-
independent manner although the speciﬁc bacterial eﬀectors
have not been identiﬁed (Hii et al., 2008). Presently, there is
limited information linking the speciﬁc bacterial eﬀectors to host
pathways. While it is beyond the scope of this study, elucidating
FIGURE 6 | Activation of signaling cascades in response to Burkholderia
spp. infection. A signaling network was constructed based on current
knowledge of signal transduction pathways and our survey of host protein
expression and phosphorylation profiles in response to Burkholderia spp.
infection. Proteins identified in the RPMA screen (green circle) and/or
characterized by immunoblotting are designated by color coding (gold circle,
confirmed by immunoblot; red, confirmed by RPMA and immunoblot). Red bold
arrow represents potential therapeutic routes.
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the bacterial-host networks will be critical for identiﬁcation of
host proteins that could be targeted for development of host-
based therapeutics.
Induction of iNOS in Response to Burkholderia
spp. Infection
Induction of iNOS upon bacterial infection of macrophages
is a host response reported to enhance antimicrobial activity
through activation of the TLR4 pathway as well as IFN signaling
(Jacobs and Ignarro, 2001; Utaisincharoen et al., 2004; Brett
et al., 2008). iNOS catalyzes production of nitric oxide (NO),
which is oxidized to reactive nitrogen oxide species that play
an important role in the clearance of intracellular bacteria
(Coleman, 2001). RAW264.7 cells infected with Bm ATCC23344
and Bm 2002721278 showed reduced levels of total IκBα in
comparison with Bp E8, suggesting elevated NF-κB activity
upon Bm infection. Moreover, production of IFN-β was elevated
in Bm infected RAW264.7 cells compared to Bp strains. This
suggests upregulation of iNOS protein expression observed in
Bm strains may thus be a result of the activity orchestrated
by NF-κB and IFN-β. In fact, multiple transcription factors
such as NF-κB, STAT1, and interferon regulatory factor (IRF)
are demonstrated to regulate the iNOS promoter (Taylor and
Geller, 2000). Notably, our results demonstrate that diﬀerential
expression of iNOS in Bm vs. Bp strains plays a role in bacterial
clearance as evidenced by bacterial survival in the presence
of AG.
Potential Targets for Anti-Inflammatory
Therapeutics in Burkholderia spp. Infection
Balancing the inﬂammatory network may direct the host
responses toward an anti-inﬂammatory state and may represent
a more eﬀective means of treatment for postsymptomatic
infections (D’Elia et al., 2013). Phosphorylation of AMPK-α1,
Src, and GSK3β upon Burkholderia spp. infection suggested
their involvement in modulating host inﬂammatory response.
First, suppression of AMPK-α1 activation via Serine 485
phosphorylation was observed in Burkholderia spp. infected
cells. This suggested that a pro-inﬂammatory mechanism was
quickly mounted in response to the infection. Potentiating
AMPK-α1 activation may mitigate the inﬂammatory response
through promoting oxidative metabolism, which is connected
to an anti-inﬂammatory state, rather than the glycolytic state
associated with inﬂammation. Secondly, the tyrosine kinase
Src mediated integrin signaling pathway not only modulates
leukocyte adhesion and migration but also negatively regulates
TLR4 activation (Han et al., 2010). In this context, activation
of Src implicates initiation of a TLR4 mediated negative
feedback mechanism. Attenuating activation of NF-κB through
potentiating Src mediated integrin signal cascade may thus
serve as a therapeutic route for Burkholderia spp. infection.
Thirdly, reduced transcriptional activity of NF-κB was associated
with GSK3β inhibition and this resulted in attenuation of
TLR mediated inﬂammatory cytokine production (Martin et al.,
2005). Bp infected mice pretreated with GSK3β inhibitor showed
reduced levels of pro-inﬂammatory cytokines (TNF-α, IFN-γ, IL-
1β) and elevated levels of anti-inﬂammatory cytokines (IL-10 and
IL1Ra). Strikingly, Bp infected mice showed improved survival
when treated with the GSK3β inhibitor (Tay et al., 2012). This
selective action of GSK3β onNF-κB-induced gene expression will
likely facilitate the therapeutic anti-inﬂammatory uses of GSK3β
inhibitors.
Burkholderia spp. Host Signal Transduction
Network
Empirical studies have characterized the function of numerous
host proteins in the context of Burkholderia spp. infection;
however, they have not been queried systematically against
multiple Burkholderia spp. Our high throughput RPMA
approach successfully identiﬁed several previously published
protein targets as well as new, unreported host proteins that were
altered in response to Burkholderia spp. infection. To the best
of our knowledge, activation of Src, inactivation of AMPK-α1
or expression of c-Myc has not been implicated as altered in
Burkholderia spp. infection. We have constructed a representative
network that encompasses critical signaling axes based on
current framework of signal transduction pathways and our
survey of host protein expression and phosphorylation proﬁles.
Canonical pathways downstream of TLR4 include several host
proteins from our studies, namely IκBα, active Src, ERK1/2, p38,
and inactive AMPK-α1. The aforementioned kinases ultimately
activate transcription factors (e.g., c-Myc, STAT1, and NF-κB)
which serve to regulate gene expression (e.g., iNOS) during
Burkholderia spp. infection (Figure 6). Based on our results,
induction of phosphorylated forms of AMPK-α1, GSK3β, and
Src in the context of canonical pathways suggest that they play
a role in regulating the inﬂammatory response of Burkholderia
spp. infections. Inhibiting AMPK-α1 (by phosphorylating Serine
485) triggers a pro-inﬂammatory mechanism whereas inhibiting
GSK3β (by phosphorylating Serine 9) may result in suboptimal
NF-κB mediate inﬂammatory response. In addition, activating
integrin associated Src kinase may negatively regulate MyD88
dependent NF-κB activation (Figure 6). Importantly, perturbing
the nodes in these pathways by antisense technology and
bioactive small molecules will serve to validate these host factors
in the pathogenesis of Burkholderia spp. infections.
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FIGURE S1 | Heat map of fold changes over mock treated samples.
RAW264.7 macrophages were infected with indicated Burkholderia spp. for 0.5,
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expression patterns and phosphorylation states of indicated proteins after
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TABLE S1 | Antibodies used in RPMA experiment. Explanations of column
headings are: Name of antibody: name of the proteins that antibodies recognize;
Vendor: the vendor of the antibodies; Catalog #: the catalog number associated
with the vendor; Molecular Weight: the size of the protein in kilo-Dalton; Host: the
source of the antibodies; Dilution: dilutions used in the PRMA.
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